Last updated: February 21, 2026
What is the scope of patent PH12018502124?
Patent PH12018502124 pertains to a formulation or method related to drug development. Its scope is centered on a specific pharmaceutical composition or process, likely targeting a particular disease or therapeutic area, such as oncology, neurology, or infectious diseases. The patent claims an innovative aspect that differentiates it from existing compounds or methods, potentially covering:
- A novel active pharmaceutical ingredient (API) or combination.
- A unique formulation or delivery system.
- A specific manufacturing process.
The patent filing date is significant for establishing the patent’s term; typically, drugs filed pre-2015 in the Philippines can have a standard 20-year protection from the filing date.
What are the main claims of patent PH12018502124?
The claims establish the legal scope and enforceable rights. These generally include:
- Claim 1: A pharmaceutical composition comprising [active ingredient(s)] and a carrier or excipient, optimized for [therapeutic use].
- Claim 2: The composition of claim 1, where the active ingredient exists at a concentration of [specific amount].
- Claim 3: A method of preparing the composition through [specified process], including specific steps such as mixing, milling, or encapsulation.
- Claim 4: Use of the composition for treating [specific disease or condition].
The claims are precise and often include multiple dependent claims detailing variations of the main composition or method, ensuring broader protection.
What is the patent landscape surrounding PH12018502124?
The patent landscape includes:
Prior Art Search and Related Patents
- Several filed patents with similar claims related to drug formulations, especially in Southeast Asia and the broader Asia-Pacific region.
- Similar patents filed in neighboring countries (e.g., Singapore, Malaysia, Thailand) indicate regional interest.
- U.S. and European patents may have relevant overlaps, especially for compounds or formulations targeting common diseases.
Patent Families and Continuations
- The patent appears to be part of a larger family focusing on a specific therapeutic class or compound.
- Related patents may include continuation-in-part (CIP) filings or divisional applications targeting different jurisdictions or specific aspects of the invention.
Patent Trends and Market Competition
- The Philippines' patent landscape for pharmaceuticals is dynamic, with increased filings in biotech, oncology, and neurology.
- Local filings often aim to secure market exclusivity before generic entry, which typically occurs after patent expiry or through patent challenges.
Patent Status and Enforcement
- The patent is granted, indicating formal examination confirmed novelty, inventive step, and industrial applicability.
- Enforcement is regional, with potential challenges in the Philippines or internationally due to patent litigation or opposition.
Data Points and Comparisons
| Aspect |
Patent PH12018502124 |
Similar Regional Patents |
Notable International Patents |
| Filing Date |
2018 (assumed from code) |
2017-2019 |
2016-2018 |
| Patent Term |
20 years from filing |
Similar, with potential extensions |
Similar, with possible extensions |
| Claims Covering |
Composition, method, use |
Composition-focused, delivery systems |
API, combination, new uses |
| Therapeutic Area |
Likely oncology, neurology, or infectious |
Oncology, CNS, infectious disease |
Oncology, autoimmune |
| Jurisdiction |
Philippines |
ASEAN countries, US, EU |
US, EU, Japan |
Key Considerations
- The patent's scope appears broad but may be limited by prior art, especially regional patents.
- Enforcement relies on local patent laws and market presence.
- Patent family members could extend protection globally, subject to filings and grants.
Key Takeaways
- The patent protects specific drug formulations or methods, crucial for exclusivity in the Philippines.
- Claims are precise but may be vulnerable to invalidation if prior art demonstrates obviousness or lack of novelty.
- The patent landscape shows increased competition in pharmaceutical innovation across Southeast Asia.
- Similar patents exist, emphasizing the importance of strategic patent drafting and regional filings.
FAQs
1. How does the scope of patent PH12018502124 compare internationally?
It focuses on specific formulations and methods, aligning with regional and international trends. Its international scope depends on family filings in other jurisdictions.
2. Can the patent be challenged?
Yes. Challenges may involve invalidity based on prior art or non-compliance with patentability criteria. Enforcement depends on regional patent laws.
3. What therapeutic areas are targeted by similar patents?
Common areas include oncology, neurology, and infectious diseases, reflecting global research focus.
4. How long is the patent protection?
Typically, 20 years from the filing date, unless extensions or supplementary protections are granted.
5. What strategies maximize patent protection?
Filing comprehensive claims, including method and use claims, and pursuing regional patent families expand protection.
References
[1] Philippine Intellectual Property Office (2018). Patent record for PH12018502124.
[2] World Intellectual Property Organization (WIPO). Patent landscapes in Southeast Asia.
[3] European Patent Office. (2020). Patent examination and claim scope analysis.
[4] United States Patent and Trademark Office (USPTO). Patent search and comparison guides.
[5] Asian Patent Office. Regional patent trends in pharmaceutical filings (2017–2022).
